Where would we be without funding from Muscular Dystrophy UK? The basic answer is we wouldn’t be anywhere.
Professor Doug Turnbull, Professor of Neurology at the University of Newcastle.
There are currently no treatments for most of the muscle-wasting conditions we support. Research generates the knowledge that is essential for understanding the cause of these conditions. This knowledge can then be used in finding effective treatments.
Since 1959 we have invested more than £55 million in high quality research into muscle-wasting conditions. This has been possible only through the generosity and dedication of our supporters.
We use a robust international peer-review system, and have laid the foundations for the first potential treatments for some muscle-wasting conditions.
We are also pressing to ensure early participation for UK patients in clinical trials. We fund clinical trial co-ordinators and the national neuromuscular database to ensure vital patient information is available to clinicians and researchers.
We won’t stop until there are treatments and cures for all muscle-wasting conditions. We cannot do this without your support – please help us now.
How to help
We are supporting high quality research to find effective treatments and cures as soon as possible. You can help now:
Useful information
News
-
2021 UK Neuromuscular Research Conference
Find out about the research updates shared at the meeting
-
Join MDUK's cooking and wine tasting event
Tickets are £125 per household and include three bottles of wine
-
SMC approves Zolgensma for restricted use
SMA gene treatment Zolgensma accepted for restricted use
-
Changing Places consultation open to 23 April
Add your voice to our biggest consultation yet
Events calendar
-
11
Virtual Royal Parks Half Marathon
11 April 2021
-
18
Brighton 10K 2021 (Brighton Marathon Weekend)
18 April 2021
-
29
An evening with William Sitwell & Jesse Dunford Wood
29 April 2021
Near you
